https://www.selleckchem.com/products/cp-43.html
Human epididymis protein 4 (HE4) is a validated, complementary biomarker to cancer antigen 125 (CA125) for high grade serous ovarian carcinoma (HGSC). Currently, there are insufficient data on the utility of longitudinal HE4 measurement during HGSC treatment and follow up. We set to provide a comprehensive analysis on the kinetics and prognostic performance of HE4 with serial measurements during HGSC treatment and follow up. This prospective study included 143 patients with advanced HGSC (ClinicalTrials.gov identifier NCT01276574). Serum
Like
Comment
Share
